Matches in Wikidata for { <http://www.wikidata.org/entity/Q92950079> ?p ?o ?g. }
- Q92950079 description "artículu científicu espublizáu en xineru de 2020" @default.
- Q92950079 description "scientific article published on 27 January 2020" @default.
- Q92950079 description "wetenschappelijk artikel" @default.
- Q92950079 description "наукова стаття, опублікована 27 січня 2020" @default.
- Q92950079 description "գիտական հոդված հրատարակված 2020 թվականի հունվարի 27-ին" @default.
- Q92950079 name "Everolimus for cardiac rhabdomyomas in children with tuberous sclerosis. The ORACLE study protocol (everOlimus for caRdiac rhAbdomyomas in tuberous sCLErosis): a randomised, multicentre, placebo-controlled, double-blind phase II trial" @default.
- Q92950079 name "Everolimus for cardiac rhabdomyomas in children with tuberous sclerosis. The ORACLE study protocol (everOlimus for caRdiac rhAbdomyomas in tuberous sCLErosis): a randomised, multicentre, placebo-controlled, double-blind phase II trial" @default.
- Q92950079 type Item @default.
- Q92950079 label "Everolimus for cardiac rhabdomyomas in children with tuberous sclerosis. The ORACLE study protocol (everOlimus for caRdiac rhAbdomyomas in tuberous sCLErosis): a randomised, multicentre, placebo-controlled, double-blind phase II trial" @default.
- Q92950079 label "Everolimus for cardiac rhabdomyomas in children with tuberous sclerosis. The ORACLE study protocol (everOlimus for caRdiac rhAbdomyomas in tuberous sCLErosis): a randomised, multicentre, placebo-controlled, double-blind phase II trial" @default.
- Q92950079 prefLabel "Everolimus for cardiac rhabdomyomas in children with tuberous sclerosis. The ORACLE study protocol (everOlimus for caRdiac rhAbdomyomas in tuberous sCLErosis): a randomised, multicentre, placebo-controlled, double-blind phase II trial" @default.
- Q92950079 prefLabel "Everolimus for cardiac rhabdomyomas in children with tuberous sclerosis. The ORACLE study protocol (everOlimus for caRdiac rhAbdomyomas in tuberous sCLErosis): a randomised, multicentre, placebo-controlled, double-blind phase II trial" @default.
- Q92950079 P1433 Q92950079-4A61E8CC-FD7C-4B14-90E5-040A58F1F881 @default.
- Q92950079 P1476 Q92950079-1706BC75-EF87-407A-A076-6A19F4B6F396 @default.
- Q92950079 P2093 Q92950079-001E8C26-1759-44C5-9093-3CB855448F1F @default.
- Q92950079 P2093 Q92950079-096C8B54-1260-41A5-8EE6-873315E27C39 @default.
- Q92950079 P2093 Q92950079-0D746A08-E9B1-4536-95E3-766482B6B1E5 @default.
- Q92950079 P2093 Q92950079-1392F1EB-4FD6-4C31-8CBF-E438510754E7 @default.
- Q92950079 P2093 Q92950079-1BCBE61E-BE98-4495-AE7A-5148115D66F4 @default.
- Q92950079 P2093 Q92950079-1D376A1F-82EA-4447-BBF7-935D842163CA @default.
- Q92950079 P2093 Q92950079-1DCD940C-FF90-4046-88AB-0D6C42357394 @default.
- Q92950079 P2093 Q92950079-30ECB2F4-1F68-40BB-A2F7-40BCDC730878 @default.
- Q92950079 P2093 Q92950079-3456C564-D8D7-4D8C-B5DB-882D2C2C8E2A @default.
- Q92950079 P2093 Q92950079-43271499-D124-4E9F-97A9-183AFDB2FF7F @default.
- Q92950079 P2093 Q92950079-4F7BF54C-06A5-4E6E-B355-DCDDF317FC8B @default.
- Q92950079 P2093 Q92950079-4FA76FDD-7067-467A-A3C0-FA5CA3F3D3CE @default.
- Q92950079 P2093 Q92950079-5A33CC56-E695-4BEB-8632-0ED6110C03F5 @default.
- Q92950079 P2093 Q92950079-64FFD84F-5DFB-4E24-8FA8-56C351E431CF @default.
- Q92950079 P2093 Q92950079-6686F396-9D72-450B-BB5F-A5D6EEB9FFE8 @default.
- Q92950079 P2093 Q92950079-68FDCD33-F525-4CAC-8E60-11EA9B2A5849 @default.
- Q92950079 P2093 Q92950079-8AD3EC4C-9D09-4CA6-95B7-17A2C31DEF73 @default.
- Q92950079 P2093 Q92950079-C3BFA95C-2AF5-4BA2-9695-151CA03108C7 @default.
- Q92950079 P2093 Q92950079-C6D3D8F5-6C3F-4755-96B9-8B4D77DFB11B @default.
- Q92950079 P2093 Q92950079-CE2803D5-0CD4-417B-BEDA-D7774A4F6059 @default.
- Q92950079 P2093 Q92950079-D13F4DF8-84A9-4B98-B2C9-DC84AD48032C @default.
- Q92950079 P2093 Q92950079-D75732FD-E1E6-4D2A-9435-04D0AB18284A @default.
- Q92950079 P2093 Q92950079-DCAB5224-3FB9-4A2B-9FAD-FBB89BF0CD34 @default.
- Q92950079 P2093 Q92950079-E225613A-ED44-46AC-B351-CF9D816239E8 @default.
- Q92950079 P2093 Q92950079-ED1D66AD-CF35-4A53-A934-73F510F44C0D @default.
- Q92950079 P2093 Q92950079-F117C85C-BB10-456F-BCA6-914D033765D0 @default.
- Q92950079 P2860 Q92950079-00DECE08-C1FB-4A5D-AA05-AB861FBED630 @default.
- Q92950079 P2860 Q92950079-027AD15E-923C-480C-8DF9-5A69B8B97417 @default.
- Q92950079 P2860 Q92950079-03129E5E-BEE9-4095-8D42-26FED161354C @default.
- Q92950079 P2860 Q92950079-0B736844-576F-44ED-89E0-830E5370EA8C @default.
- Q92950079 P2860 Q92950079-10425ECD-EF55-4FDB-A4E2-FF9E913F4EDF @default.
- Q92950079 P2860 Q92950079-2A25B290-660A-4830-9E45-812CC0821ABF @default.
- Q92950079 P2860 Q92950079-344122D9-3632-4F0F-9B9B-BD2192ED4F6F @default.
- Q92950079 P2860 Q92950079-389205B0-8436-42B4-A5BF-5D77014FC405 @default.
- Q92950079 P2860 Q92950079-46D43D10-43EA-4F5B-8C8D-4B78D63B9CB0 @default.
- Q92950079 P2860 Q92950079-4BD18C1C-6360-401A-AC57-538D892A4689 @default.
- Q92950079 P2860 Q92950079-575F5E8F-8830-47EB-A091-AFDEC17CF51E @default.
- Q92950079 P2860 Q92950079-66B8AE5D-4975-4A54-AA7E-50FCAE86C383 @default.
- Q92950079 P2860 Q92950079-7F84335B-E7A5-456C-9774-B37864774805 @default.
- Q92950079 P2860 Q92950079-8F71F534-2F32-495B-AD66-F873D15A56CE @default.
- Q92950079 P2860 Q92950079-A252358B-B4F1-43AB-B6B3-BFF0EB0CEBEA @default.
- Q92950079 P2860 Q92950079-AD14CD36-6C32-4E03-97FD-D00F77E3E41D @default.
- Q92950079 P2860 Q92950079-B2EE418F-7229-4BA6-B114-17B4DADF1F45 @default.
- Q92950079 P2860 Q92950079-B914FB3B-EF55-426D-9A39-F0A77EC98CE1 @default.
- Q92950079 P2860 Q92950079-BB119466-B37C-4C30-9D38-DB88C32A268B @default.
- Q92950079 P2860 Q92950079-BC7C99C8-DEEA-44ED-A00C-E5BEF72C42F0 @default.
- Q92950079 P2860 Q92950079-BFA55267-8DEF-45AB-9D71-4DCA4A4BF172 @default.
- Q92950079 P2860 Q92950079-CB163B3B-742F-40D4-82C0-BA6827FAB587 @default.
- Q92950079 P2860 Q92950079-D6C730EC-1B39-4D5F-9680-C7B7E9D182D4 @default.
- Q92950079 P2860 Q92950079-DB7F973F-9B2D-479A-8D1F-4CE13DE1A94F @default.
- Q92950079 P2860 Q92950079-E68E36F2-6DA1-4B58-AF2E-4616787657B5 @default.
- Q92950079 P2860 Q92950079-EADB8C45-4C7C-4724-850E-46401943AFDF @default.
- Q92950079 P2860 Q92950079-ED1D9751-C43A-43A1-A481-34A8886F8C4D @default.
- Q92950079 P2860 Q92950079-EE130822-0732-4036-A563-B2F1630FB25B @default.
- Q92950079 P2860 Q92950079-F748669A-1D69-4E79-ACE5-7B44ACDF6A07 @default.
- Q92950079 P304 Q92950079-AB0E32AA-3B81-4A3E-BCC1-5FF8A4685B5E @default.
- Q92950079 P31 Q92950079-AFF59EBE-4F1A-4140-A149-BFDC66081DAF @default.
- Q92950079 P356 Q92950079-9ACAAE61-2CAE-4243-983E-AD35E3949A97 @default.
- Q92950079 P433 Q92950079-1145DAAF-B8BF-41C6-9411-1D5D52D6483E @default.
- Q92950079 P478 Q92950079-03F763BE-E0AE-4979-9B69-B79DCC9E2AD6 @default.
- Q92950079 P50 Q92950079-0784FF76-A25C-460D-95D7-90C28F4C50F9 @default.
- Q92950079 P50 Q92950079-6D3556A2-BD70-4F70-962F-140404708969 @default.
- Q92950079 P577 Q92950079-58DF3E34-5E72-4090-9B13-34ADC6759EE4 @default.
- Q92950079 P698 Q92950079-29136978-3A0E-439C-BF3A-B2BB77EE2A69 @default.
- Q92950079 P921 Q92950079-3AFBEABA-3867-47BD-B08C-EF35D7C81421 @default.
- Q92950079 P921 Q92950079-538B3193-0227-4D1A-A796-4BAC8CDBAADB @default.
- Q92950079 P921 Q92950079-AC54F0F8-2178-4F84-B96B-40B8E4CFC2CC @default.
- Q92950079 P921 Q92950079-BF33E5B3-3400-4EED-9D91-E106865043D8 @default.
- Q92950079 P921 Q92950079-CA8D057B-D251-479A-9607-A767C7F11EAE @default.
- Q92950079 P356 S1047951119003147 @default.
- Q92950079 P698 31983379 @default.
- Q92950079 P1433 Q2041555 @default.
- Q92950079 P1476 "Everolimus for cardiac rhabdomyomas in children with tuberous sclerosis. The ORACLE study protocol (everOlimus for caRdiac rhAbdomyomas in tuberous sCLErosis): a randomised, multicentre, placebo-controlled, double-blind phase II trial" @default.
- Q92950079 P2093 "Alberto Farina" @default.
- Q92950079 P2093 "Anna Stein" @default.
- Q92950079 P2093 "Anthony Gutierrez" @default.
- Q92950079 P2093 "Antonio F Raquelo-Menegassio" @default.
- Q92950079 P2093 "Carla Manterola" @default.
- Q92950079 P2093 "Carolina F de Sousa" @default.
- Q92950079 P2093 "Carolina Victor" @default.
- Q92950079 P2093 "Daniella B Parente" @default.
- Q92950079 P2093 "Dina Maki" @default.
- Q92950079 P2093 "Elias M Morón" @default.
- Q92950079 P2093 "Fabiano F de Abrantes" @default.
- Q92950079 P2093 "Fatima Iqbal" @default.
- Q92950079 P2093 "Jazmin Camacho-Vilchez" @default.